ArticleTherapeutic advances in medical oncology2023

Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.

Emma Zattarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.